XBiotech
(NASDAQ) XBIT
XBiotech Financials at a Glance
Market Cap
$71.65M
Revenue (TTM)
$0.00
Net Income (TTM)
$45.54M
EPS (TTM)
$-1.49
P/E Ratio
-1.57
Dividend
$0.00
Beta (Volatility)
1.05 (Average)
Dividend
$0.00
Beta (Volatility)
1.05 (Average)
Price
$2.35
Volume
9
Open
$2.35
Price
$2.35
Volume
9
Open
$2.35
Previous Close
$2.35
Daily Range
$2.35 - $2.35
52-Week Range
$2.09 - $3.62
Dividend
$0.00
Beta (Volatility)
1.05 (Average)
Price
$2.35
Volume
9
Open
$2.35
Previous Close
$2.35
Daily Range
$2.35 - $2.35
52-Week Range
$2.09 - $3.62
XBIT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout XBiotech
Industry
Biotechnology
Sector
Health CareEmployees
85
CEO
Sushma Shivaswamy, PhD
Website
www.xbiotech.comHeadquarters
Austin, TX 78744, US
XBIT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-28%
Return on Capital
-39%
Return on Assets
-30%
Earnings Yield
-63.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$71.65M
Shares Outstanding
30.49M
Volume
9
Short Interest
0.00%
Avg. Volume
43.16K
Financials (TTM)
Gross Profit
$1.69M
Operating Income
$55.69M
EBITDA
$54.00M
Operating Cash Flow
$39.92M
Capital Expenditure
$289.00K
Free Cash Flow
$40.21M
Cash & ST Invst.
$125.55M
Total Debt
$0.00
XBiotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$378.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$71.65M
N/A
Market Cap/Employee
$778.76K
N/A
Employees
92
N/A
Net Income
$26.89M
-155.9%
EBITDA
$29.38M
-196.6%
Quarterly Fundamentals
Net Cash
$125.55M
-22.7%
Accounts Receivable
$360.00K
-58.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-30.34%
N/A
Return on Invested Capital
-39.17%
N/A
Free Cash Flow
$22.99M
-247.0%
Operating Cash Flow
$22.95M
-250.9%